Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Ozempic (semaglutide) mimics the natural hormone GLP-1, activating receptors in the brain that regulate hunger and satiety. This reduces food cravings, decreases appetite, and helps you feel full with smaller portions — making it easier to maintain a caloric deficit for sustained weight loss.
Ozempic 1mg slows the rate at which food leaves your stomach, prolonging feelings of fullness after meals. This natural mechanism reduces overall calorie intake without requiring strict dietary restriction. Combined with appetite suppression, Ozempic creates a powerful, sustainable weight loss environment.
The STEP 1 clinical trial demonstrated that semaglutide 1mg achieved an average body weight reduction of 14.9% over 68 weeks — significantly more than diet and exercise alone. Over 80% of participants lost at least 5% of their body weight, and over 50% lost at least 15%.
Answer our secure online health questionnaire covering your medical history, current medications, weight history, and weight loss goals. Our HIPAA-compliant platform ensures your information stays private while giving our physicians everything they need to evaluate your Ozempic eligibility.
A board-certified physician reviews your intake within 24–48 hours and, if you qualify, prescribes Ozempic with a personalized dose escalation plan starting at 0.25mg, increasing to 0.5mg, then to the 1mg maintenance dose as you tolerate it.
Your Ozempic prescription is fulfilled at a licensed pharmacy and shipped discreetly to your door within 2–5 business days. Ongoing physician check-ins monitor your progress and adjust dosing as needed throughout your weight loss journey.
Semaglutide Injection — 1mg Maintenance Dose
Ozempic 1mg is the standard maintenance dose for weight management in adults with obesity. Once-weekly subcutaneous injection with guided escalation from 0.25mg. Clinical data: 14.9% average body weight reduction at 68 weeks (STEP 1 trial). FDA-approved and physician-prescribed.
Get Ozempic 1mg OnlineHigher-Dose Semaglutide — FDA-Approved for Obesity
Wegovy is semaglutide at the 2.4mg weekly dose, specifically FDA-approved for chronic weight management. Clinical trials show an average 15–17% body weight reduction. Your physician will recommend whether Ozempic 1mg or Wegovy 2.4mg is the best semaglutide option for your health profile.
Explore Semaglutide OptionsDual GLP-1/GIP Agonist — Up to 22% Weight Loss
For patients seeking maximum weight loss efficacy, tirzepatide (Mounjaro®/Zepbound®) is also available through our platform. This dual GLP-1/GIP receptor agonist achieves up to 22.5% body weight reduction in clinical trials — the highest of any FDA-approved weight loss medication.
Explore TirzepatideAdult obesity rates (CDC Behavioral Risk Factor Surveillance System, 2023) vary significantly across the United States. States with higher obesity prevalence experience the greatest demand for accessible GLP-1 telehealth prescriptions:
Source: CDC Behavioral Risk Factor Surveillance System (BRFSS) 2023. Adult obesity defined as BMI ≥ 30.0.
Our board-certified physicians prescribe Ozempic 1mg online in every US state. Select your state to check Ozempic eligibility near you.
Ozempic 1mg is a once-weekly semaglutide injection — a GLP-1 receptor agonist that mimics the natural hormone GLP-1 to reduce appetite, slow gastric emptying, and lower blood sugar. The 1mg dose is the standard maintenance dose for adults with obesity or overweight with weight-related conditions. Clinical trials (STEP 1) demonstrated an average of 14.9% body weight reduction over 68 weeks at the 1mg dose.
You may be eligible for Ozempic 1mg if you have a BMI of 30 or higher (obese), or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, hypertension, or high cholesterol. Our board-certified physicians review your health profile via secure telehealth to determine eligibility — no in-person visit required.
Ozempic is started at 0.25mg once weekly for 4 weeks to minimize side effects, then increased to 0.5mg for 4+ weeks, and escalated to the 1mg maintenance dose. Your physician monitors your progress and adjusts the timeline based on your tolerance and response. Most patients reach the 1mg dose within 8–12 weeks of starting treatment.
Common side effects of Ozempic 1mg include nausea, diarrhea, vomiting, constipation, and stomach pain — most commonly during the dose escalation period. These typically improve as your body adjusts. Serious but rare side effects include pancreatitis, gallbladder problems, and a potential risk of thyroid tumors in people with a family history of medullary thyroid carcinoma.
After completing our online health intake, a board-certified physician typically reviews your case within 24–48 hours. Once approved, your Ozempic prescription is sent to a licensed pharmacy and shipped to your door within 2–5 business days. The entire process from consultation to delivery typically takes under one week.
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 6, 2026
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
